Propofol Versus Midazolam+Alfentanil for Sedation During Bronchoscopy: Comparison by Cutaneous Carbon Dioxide Tension
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
Although propofol is a popular agent for sedation during flexible bronchoscopy, some
clinicians have raised concerns that it may cause greater respiratory drive reduction than
more common drugs. However, this factor is difficult to accurately examine with pulse
oximetry. The introduction of a novel device that noninvasively measures carbon dioxide (CO2)
levels can help to resolve this controversy. The aim of this study is to evaluate the safety
of conscious sedation with midazolam+alfentanil compared to propofol.